MSN Laboratories Private Limited — China drug registrations and re-registration deadlines
8 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-06-29.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220098 | Oseltamivir Phosphate Capsules 磷酸奥司他韦胶囊 | 2027-12-29 | 2027-06-29 |
| 国药准字HJ20220099 | Oseltamivir Phosphate Capsules 磷酸奥司他韦胶囊 | 2027-12-29 | 2027-06-29 |
| 国药准字HJ20240001 | Deferasirox Tablets 地拉罗司片 | 2029-01-08 | 2028-07-08 |
| 国药准字HJ20240038 | Deferasirox Granules 地拉罗司颗粒 | 2029-06-10 | 2028-12-10 |
| 国药准字HJ20240039 | Deferasirox Granules 地拉罗司颗粒 | 2029-06-10 | 2028-12-10 |
| 国药准字HJ20240064 | Trientine Hydrochloride Capsules 盐酸曲恩汀胶囊 | 2029-06-27 | 2028-12-27 |
| 国药准字HJ20250110 | Nilotinib Capsules 尼洛替尼胶囊 | 2030-09-08 | 2030-03-08 |
| 国药准字HJ20250111 | Nilotinib Capsules 尼洛替尼胶囊 | 2030-09-08 | 2030-03-08 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.